{{Rsnum
|rsid=1063537
|Gene=ADIPOQ
|Chromosome=3
|position=186856286
|Orientation=plus
|GMAF=0.141
|Gene_s=ADIPOQ,ADIPOQ-AS1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 78.8 | 21.2 | 0.0
| HCB | 50.7 | 44.1 | 5.1
| JPT | 52.2 | 41.6 | 6.2
| YRI | 99.3 | 0.7 | 0.0
| ASW | 91.2 | 8.8 | 0.0
| CHB | 50.7 | 44.1 | 5.1
| CHD | 49.5 | 41.1 | 9.3
| GIH | 76.2 | 22.8 | 1.0
| LWK | 95.5 | 4.5 | 0.0
| MEX | 72.4 | 24.1 | 3.4
| MKK | 76.3 | 20.4 | 3.3
| TSI | 69.6 | 28.4 | 2.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20930713
|Title=Associations of SNPs in ADIPOQ and subclinical cardiovascular disease in the multi-ethnic study of atherosclerosis (MESA)
|OA=1
}}

{{PMID Auto
|PMID=18523726
|Title=Adiponectin gene ADIPOQ SNP associations with serum adiponectin in two female populations and effects of SNPs on promoter activity.
|OA=1
}}

{{PMID Auto
|PMID=24414038
|Title=Association of four insulin resistance genes with type 2 diabetes mellitus and hypertension in the Chinese Han population
|OA=1
}}

{{PMID Auto
|PMID=24894086
|Title=Adiponectin gene (ADIPOQ) polymorphisms correlate with the progression of nephropathy in Taiwanese male patients with type 2 diabetes
}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}